Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04938648 · ClinicalTrials.gov registry record · NA
Aligning Medications With What Matters Most
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
NCT04938648: Completed NA study, sponsored by Johns Hopkins University.
NCT04938648 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 138 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04938648, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
Study Summary
The Aligning Medications with What Matters Most (ALIGN) study will assess the feasibility and preliminary efficacy of a deprescribing intervention to reduce medication regimen complexity and treatment burden for people living with dementia (PLWD) and their care partners.
Interventions
- BEHAVIORAL Pharmacist-led deprescribing intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2021-06-03 |
| Est. Completion | 2022-05-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04938648
The ClinicalTrials.gov registry entry for NCT04938648 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacist-led deprescribing intervention is the first listed.
NCT04938648 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04938648 about?
NCT04938648 is a clinical study titled "Aligning Medications With What Matters Most". The Aligning Medications with What Matters Most (ALIGN) study will assess the feasibility and preliminary efficacy of a deprescribing intervention to reduce medication regimen complexity and treatment burden for people living with dementia (PLWD) and their care partners.
What is the current status of trial NCT04938648?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2021-06-03. Estimated completion is 2022-05-02.
What interventions are being tested in trial NCT04938648?
The interventions under investigation include: Pharmacist-led deprescribing intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04938648?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.